Stock GUARD GUARD THERAPEUTICS INTERNATIONAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Guard Therapeutics International AB

Equities

GUARD

SE0021181559

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 08:59:57 10/05/2024 pm IST 		5-day change 1st Jan Change
33 SEK +8.55% Intraday chart for Guard Therapeutics International AB +10.00% -7.82%
08/05 Guard Therapeutics International AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
15/04 Guard Therapeutics Receives First Regulatory Approval for the Phase 2b Study POINTER CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 161.8 200.4 452.2 273.1 360.2 332 - -
Enterprise Value (EV) 1 107.9 110.3 452.2 72.77 360.2 262 286 332
P/E ratio -3.62 x -6.84 x -3.56 x -2.49 x -3.18 x -3.35 x -3.35 x 1.45 x
Yield - - - - - - - -
Capitalization / Revenue - - - - - - - -
EV / Revenue - - - - - - - -
EV / EBITDA -2.7 x -2.75 x -5.52 x -0.63 x -3.13 x -2.65 x -2.89 x 1.45 x
EV / FCF -1.79 x -2.91 x -5.83 x -0.71 x - -2.3 x -2.89 x -
FCF Yield -55.9% -34.4% -17.2% -140% - -43.5% -34.6% -
Price to Book - - 2.57 x 1.58 x - 4.93 x 7.67 x 1.22 x
Nbr of stocks (in thousands) 3,082 3,082 6,862 6,862 10,062 10,062 - -
Reference price 2 52.50 65.00 65.90 39.80 35.80 33.00 33.00 33.00
Announcement Date 27/02/20 24/02/21 22/02/22 22/02/23 21/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - - - - -
EBITDA 1 -39.9 -40.12 -81.9 -114.9 -115.1 -99 -99 229
EBIT 1 -44.28 -40.28 -81.9 -114.9 -115.1 -99 -99 229
Operating Margin - - - - - - - -
Earnings before Tax (EBT) 1 -45.16 -40.28 -82.03 -112.8 -113.3 -99 -99 -
Net income 1 -45.16 -40.28 -82.03 -112.8 -113.3 -99 -99 -
Net margin - - - - - - - -
EPS 2 -14.50 -9.500 -18.50 -16.00 -11.26 -9.850 -9.850 22.70
Free Cash Flow 1 -60.28 -37.96 -77.59 -102.1 - -114 -99 -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 27/02/20 24/02/21 22/02/22 22/02/23 21/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales 1 - - - - -
EBITDA 1 -22.56 - -21.86 -34.13 -39.79
EBIT 1 -22.56 - -21.86 -34.13 -39.79
Operating Margin - - - - -
Earnings before Tax (EBT) - - - - -
Net income 1 -22.71 -18.98 -21 -32.37 -40.49
Net margin - - - - -
EPS 2 -4.500 -3.000 -3.000 -4.500 -5.500
Dividend per Share - - - - -
Announcement Date 22/02/22 12/05/22 23/08/22 16/11/22 22/02/23
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 54 90 - 200 - 70 46 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -60.3 -38 -77.6 -102 - -114 -99 -
ROE (net income / shareholders' equity) - -60.9% -64.2% -63.9% - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - - 25.60 25.10 - 6.700 4.300 27.00
Cash Flow per Share - - -17.40 -14.50 - - - -
Capex 0.07 - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 27/02/20 24/02/21 22/02/22 22/02/23 21/02/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GUARD THERAPEUTICS INTERNATIONAL AB Stock Guard Therapeutics International AB
-7.82% 30.64M
MODERNA, INC. Stock Moderna, Inc.
+17.96% 44.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.17% 42.65B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.42% 26.08B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.39% 19.03B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.86% 12.75B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.29% 12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.50% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. GUARD Stock
  4. Financials Guard Therapeutics International AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW